(19)
(11) EP 1 480 565 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.04.2009 Bulletin 2009/14

(45) Mention of the grant of the patent:
10.12.2008 Bulletin 2008/50

(21) Application number: 03716279.9

(22) Date of filing: 03.03.2003
(51) International Patent Classification (IPC): 
A61B 17/00(2006.01)
(86) International application number:
PCT/US2003/006473
(87) International publication number:
WO 2003/073944 (12.09.2003 Gazette 2003/37)

(54)

VASCULAR OCCLUSION DEVICE

VASKULÄRE OKKLUSIONSVORRICHTUNG

DISPOSITIF D'OCCLUSION VASCULAIRE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 01.03.2002 US 361122 P

(43) Date of publication of application:
01.12.2004 Bulletin 2004/49

(73) Proprietor: REGENTS OF THE UNIVERSITY OF MINNESOTA
Minneapolis, Minnesota 55455-2070 (US)

(72) Inventor:
  • DAS, Gladwin, S.
    Arden Hills, MN 55112 (US)

(74) Representative: Preuss, Udo 
Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3
80335 München
80335 München (DE)


(56) References cited: : 
WO-A-01/17435
GB-A- 2 269 321
US-A- 5 342 393
US-A- 5 827 325
US-B1- 6 312 446
 WO-A-96/32882
US-A- 5 312 435
US-A- 5 350 399
US-A- 5 904 703
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).